Baker Brothers Advisors - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 138 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$225,648,303
-36.8%
1,545,1130.0%1.30%
-37.1%
Q2 2023$356,921,103
-4.6%
1,545,1130.0%2.07%
+1.4%
Q1 2023$374,319,075
-16.5%
1,545,1130.0%2.04%
-24.4%
Q4 2022$448,469,048
+360.3%
1,545,113
+3.1%
2.69%
+322.1%
Q3 2022$97,434,000
-9.2%
1,499,2130.0%0.64%
+4.8%
Q2 2022$107,314,000
-27.0%
1,499,2130.0%0.61%
-27.9%
Q1 2022$147,103,000
+15.8%
1,499,2130.0%0.84%
+36.7%
Q4 2021$127,043,000
+6.2%
1,499,2130.0%0.62%
+17.7%
Q3 2021$119,622,000
-18.1%
1,499,2130.0%0.52%
-18.1%
Q2 2021$146,038,000
-16.7%
1,499,2130.0%0.64%
-15.7%
Q1 2021$175,363,000
+5.2%
1,499,2130.0%0.76%
+21.0%
Q4 2020$166,668,000
-6.4%
1,499,2130.0%0.63%
-11.7%
Q3 2020$178,002,000
+4.8%
1,499,213
+0.0%
0.71%
-5.1%
Q2 2020$169,786,000
+69.6%
1,499,2120.0%0.75%
+21.6%
Q1 2020$100,087,000
-6.1%
1,499,212
+28.2%
0.62%
+8.8%
Q4 2019$106,533,000
+5.7%
1,169,2780.0%0.57%
-17.5%
Q3 2019$100,815,000
-17.7%
1,169,2780.0%0.69%
-17.6%
Q2 2019$122,552,000
-16.3%
1,169,2780.0%0.83%
-11.2%
Q1 2019$146,464,000
+11.1%
1,169,2780.0%0.94%
-13.1%
Q4 2018$131,801,000
-47.4%
1,169,2780.0%1.08%
-34.6%
Q3 2018$250,377,000
-23.4%
1,169,2780.0%1.65%
-32.9%
Q2 2018$327,035,000
+354.8%
1,169,278
+89.9%
2.46%
+303.4%
Q1 2018$71,906,000
+27.2%
615,6840.0%0.61%
+24.3%
Q4 2017$56,514,000
+2075.3%
615,684
+965.9%
0.49%
+2233.3%
Q3 2017$2,598,000
+176.7%
57,7620.0%0.02%
+162.5%
Q2 2017$939,000
+5.5%
57,7620.0%0.01%
+14.3%
Q1 2017$890,000
+3.4%
57,7620.0%0.01%
-12.5%
Q4 2016$861,000
+17.6%
57,7620.0%0.01%
+14.3%
Q3 2016$732,00057,7620.01%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Tao Capital Management LP 77,657$11,3428.78%
University of Wisconsin Foundation 40,133$5,861,0236.72%
Paulson & Co. 500,000$73,020,0006.53%
TCG Crossover Management, LLC 179,917$26,275,0793.87%
Avoro Capital Advisors LLC 1,555,000$227,092,2003.54%
Affinity Asset Advisors, LLC 85,000$12,413,4003.49%
Ghost Tree Capital, LLC 57,500$8,397,3002.76%
Lynwood Capital Management Inc. 5,000$730,2001.92%
MPM BioImpact LLC 40,859$5,967,0481.59%
Tri Locum Partners LP 33,761$4,930,4561.58%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders